Previous 10 | Next 10 |
New York City, NY: April 17, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Carboplatin Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer upda...
HERTFORDSHIRE, England and PITTSBURGH , April 15, 2020 /PRNewswire/ -- The Mylan N.V. (NASDAQ: MYL) Board of Directors today announced the appointment of Robert J. Coury , previously chairman of the Mylan Board, to the position of executive chairman of Mylan. Given the unpreced...
NEW YORK, NY / ACCESSWIRE / April 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Mylan N.V. (NASDAQ:MYL) and Pfizer Inc. is fair to Mylan shareholders. On July 29, 2019, Mylan and Pfizer announced a definitive agreement to combine ...
Big pharmaceutical companies and small biotechs alike have jumped into the race to develop treatments and vaccines for the novel coronavirus disease COVID-19. Pfizer (NYSE: PFE) ranks as one of the biggest of the big pharma companies and has several COVID-19 efforts under way. Moderna (NA...
In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different. Because of the coronavirus pandemic and the subsequent stock market plunge, this month is a very good time t...
Earlier this year, Biogen (NASDAQ: BIIB) dodged a bullet when it won a patent challenge to its multiple sclerosis (MS) drug, Tecfidera, in a lawsuit brought before the U.S. Patent Trial and Appeal Board by Mylan (NASDAQ: MYL) . Had Biogen lost this lawsuit, it would have meant seri...
New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Atovaquone and Proguanil Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates and information relate...
New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Brazilian Hemorrhagic Fever (BzHF) Treatment Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates an...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Things are pretty tense in the oil markets ahead of a virtual meeting of the alliance of OPEC and non-O...
Mylan N.V. ( MYL +5.7% ) announces that its production of malaria med hydroxychloroquine sulfate at its Morgantown, WV site has advanced ahead of schedule and has enabled the supply of additional product earlier than expected for COVID-19 patients. More news on: Mylan N.V., Healthcare ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...